Oyekoya (Koya) Ayonrinde (@GutLiver) header
Oyekoya (Koya) Ayonrinde (@GutLiver) profile picture

Gastroenterologist/ Hepatologist, Clinician Researcher. MD PhD FRACP FAASLD FASGE. #NAFLD #MAFLD #MASLD, Liver Fibrosis #Cardiometabolic, #DOHaD, #UGIB, #Polyps

Australia
Joined February 2020
Photo by Oyekoya (Koya) Ayonrinde (@GutLiver)Photo by Oyekoya (Koya) Ayonrinde (@GutLiver)Photo by Oyekoya (Koya) Ayonrinde (@GutLiver)Photo by Oyekoya (Koya) Ayonrinde (@GutLiver)Photo by Oyekoya (Koya) Ayonrinde (@GutLiver)Photo by Oyekoya (Koya) Ayonrinde (@GutLiver)Photo by Oyekoya (Koya) Ayonrinde (@GutLiver)Photo by Oyekoya (Koya) Ayonrinde (@GutLiver)Photo by Oyekoya (Koya) Ayonrinde (@GutLiver)Photo by Oyekoya (Koya) Ayonrinde (@GutLiver)
If you like the sound of L-CKM Syndrome, then check out our review in Heart Lung and Circulation “Connecting the Dots: Hepatic Steatosis as a Central Player in the Choreography of the Liver-Cardiovascular-Kidney-Metabolic” See article link:
authors.elsevier.com/sd/arti…
1
5
537
Relationship between #SLD and #CAD … A systematic review. The liver holds secrets for the ❤️ @cardiacimager @AIhdayhid @OlynykJohn @rajuchila05 jacc.org/doi/epdf/10.1016/j.…
Hepatic Steatosis and High-Risk Coronary Plaque: A Systematic Review | JACC: Cardiovascular Imaging jacc.org/doi/10.1016/j.jcmg.…
1
180
The Raine Study…one of the most successful multigenerational longitudinal cohort studies in the world. Started as a pregnancy and birth cohort and now 35 years later…going strong. @RaineStudy @UWAresearch @uwanews
1
1
5
263
Professor Susan Morton, on …”the value of cohort studies”
1
80
Genesis Forum Association of Nigerian doctors in Western Australia had an inaugural medical conference today. Topics were #dementia by @asanakpan , steatotic liver disease by @GutLiver , coronary CT imaging, diabetes, adolescent mental health, stroke + a student presentation.
5
1
3
375
Proud of this paper in collaboration with @james_fiori that provides some reassurance about risks of metachronous CRC when biopsies or polypectomy are performed in the same colonoscopy as when CRC is diagnosed. Keep an👁️ on anastomoses. doi.org/10.1007/s00384-024-0… @stevenbollipo
1
3
5
1,031
This is important! While liver fibrosis is a deserved outcome to prevent and treat to reduce cirrhosis and liver cancer, liver fat also matters. The more the amount of liver fat, the higher the risk of type 2 diabetes and heart disease.
Here is another very interesting poster from this week's American Diabetes Association conference. "The leading cause of death in patients with steatotic liver disease (SLD) is CVD." "As SLD is frequently associated with metabolic disorders such as type 2 diabetes (DM), the concept of MASLD has been proposed. MASLD can be classified according to the type of associated metabolic dysfunction. Among MASLD subtypes, MASLD with DM (DM-MASLD) was shown to have a major impact on the development of CVD. However, the presence of SLD and status of concomitant metabolic abnormalities change over time. Since it is unclear how the incidence of CVD changes when DM-MASLD transitions, this study aimed to clarify this issue." "Changes in incidence of CVD due to changes in DM and MASLD status are shown in Figure 1. Remission in DM and MASLD each significantly reduced the incidence of CVD. Remission of hepatic steatosis in DM-MASLD patients was comparable to remission of DM in preventing new onset of CVD." Poster: 1278-P - Changes in Cardiovascular Disease (CVD) Incidence Due to Remission of Diabetes and Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD). Poster lead author: Yasuhiro Matsubayashi. @EASLnews @AASLDtweets @CASLupdates @EuropeLiver @GlobalLiver @scottisaacsmd @ISGLOBALorg
2
324
Is it okay to simply report that a person has a steatotic or fatty liver? How much liver fat matters?A rising number of studies find severity of hepatic steatosis matters for cardiovascular, liver and all-cause mortality. Ultrasound technologies may help - doi.org/10.1016/j.ultrasmedb…
1
3
257
The long term trajectory of severity of hepatic steatosis provides a window to future cardiometabolic health. Excessive alcohol intake in steatotic liver disease increases harm to the liver.
1
116
What #barriers limit #exercise in adults with #MASLD? Ask and they will tell. Barriers to Exercise in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Patient Survey by PhD candidate ked.deshpande @JOCMR_journal @OlynykJohn @EdithCowanUni @CurtinUni
1
1
7
609
Exercise advice could have low impact if you don’t understand why people with #MASLD won’t or can’t #exercise. Knowledge of the #barriers, #options and #opportunities can guide exercise strategies. If you don’t understand it, how can you advice them? @EuropeLiver @JOCMR_journal
1
1
3
441
👆🏾Open access doi: doi.org/10.14740/jocmr5113 Consider lack of #awareness of benefits and types of #exercise for #MASLD, perceived time constraints, physical and mental health problems, lack of enjoyment in exercise, and #fatigue as potential barriers to exercise.
1
158